Noura El-Ahmady El-Naggar, Ragaa A Hamouda, Naglaa Elshafey
Journal: Scientific reports 2024;14(1):29625
PMID: 39609450
The bacterial L-asparaginase is a highly effective chemotherapeutic drug and a cornerstone of treatment protocols used for treatment the acute lymphoblastic leukemia in pediatric oncology. A potential actinomycete isolate, Streptomyces sp. strain NEAE-99, produces glutaminase-free L-asparaginase was isolated from a soil sample. This potential strain was identified as S. violaceoruber strain NEAE-99. The central composite design (CCD) approach was utilized for finding the optimal values for four variables including the mixture of soybean and wheat bran in a 1:1 ratio (w/w), the concentrations of dextrose, L-asparagine, and potassium nitrate under solid state fermentation conditions. Through the use of an artificial neural network (ANN), the production of L-asparaginase by S. violaceoruber has been investigated, validated, and predicted in comparison to CCD. It was found that the optimal predicted conditions for maximum L-asparaginase production (216.19 U/gds) were 8.46 g/250 mL Erlenmeyer flask of soybean and wheat bran mixture in a 1:1 ratio (w/w), 2.2 g/L of dextrose, 18.97 g/L of L-asparagine, and 1.34 g/L of KNO. The experimental results (207.55 U/gds) closely approximated the theoretical values (216.19 U/gds), as evidenced by the validation. This suggests that the ANN exhibited a high degree of precision and predictive capability.
© 2024. The Author(s).
Full Text Sources:
Miscellaneous:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.